Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study
暂无分享,去创建一个
S. Vermeire | T. Hibi | G. Rogler | R. Fogel | Mamoru Watanabe | L. Peyrin-Biroulet | W. Sandborn | B. Feagan | E. Loftus | S. Danese | R. Filip | S. Nijhawan | J. McNally | R. Kempiński | C. Yun | R. Besuyen | Chantal Tasset | Sally Zhao | S. Schreiber | I. Hospodarskyy | Xiaopeng Liu